Navigation Links
Kroger Recalls Select Ice Cream Products Due to Possible Health Risk
Date:1/19/2009

CINCINNATI, Jan. 19 /PRNewswire/ -- The Kroger Co. (NYSE: KR) said today it is recalling Private Selection Peanut Butter Passion Ice Cream sold in select stores because the peanut butter in the ice cream was supplied by Peanut Corporation of America and may be contaminated with Salmonella. Stores under the following names are included in this recall: City Market, Fred Meyer, Fry's, King Soopers, QFC and Smith's.

Stores the company operates under the following names did not receive any of the ice cream being recalled: Kroger, Ralphs, Dillons, Food 4 Less, Foods Co., Jay C, Scott's, Owen's, Baker's, Gerbes, Hilander and Pay Less.

No illnesses have been reported in connection with the ice cream.

The FDA has indicated that Peanut Corporation of America is the focus of its investigation into Salmonella-related illnesses that may be linked to contaminated peanut butter.

    Item Description:

    Kroger is recalling the following ice cream:

    -- Private Selection Peanut Butter Passion Ice Cream sold in 48-ounce
       containers with a "Sell by" date of 9-13-2009 under the following UPC
       Code Number:  0001111054437.
    -- Private Selection Peanut Butter Passion Ice Cream sold in 56-ounce
       containers with a "Sell by" date of 8-11-2009 under the following UPC
       Code Number:  0001111052816.

The ice cream was sold in City Market, Fred Meyer, Fry's, King Soopers, QFC and Smith's stores in the following states: Alaska, Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.

Customers who have recently purchased this ice cream should not eat it and return the product to a store for a full refund or replacement.

No other Kroger products are involved in the recall. Kroger continues to follow FDA guidelines and, for the safety of customers, has withdrawn other products from sale that contain peanut butter ingredients implicated in this outbreak, as directed by the FDA and suppliers involved.

Salmonella is an organism that can cause serious and sometimes fatal infections, particularly in young children, the elderly, and persons with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and/or abdominal pain. For more information, please visit the Centers for Disease Control and Prevention's Web site at www.cdc.gov.

According to the FDA, peanut butter sold in jars, including Kroger brand peanut butter sold in the retailer's family of stores, is not involved in the ongoing investigation.

Consumers who have questions about the ice cream recall may contact Kroger toll-free at (800) 632-6900. For more information, please visit www.kroger.com/recalls.


'/>"/>
SOURCE The Kroger Co.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court
2. Kroger and The Little Clinic Establish Partnership to Offer Customers Convenient Healthcare Centers Inside Their Neighborhood Store
3. Kroger and Its Family of Stores Expand Discounted Generic Drug Program
4. Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute
5. Deli Chef Tri-Bean Salad Recalled From Some Kroger Stores
6. Kroger Pink Tag Campaign to Raise $2.5 Million for Breast Cancer Awareness in October
7. Peanut Butter Product Recalls Mount
8. Ralcorp Frozen Bakery Products Recalls Food Lion Bake Shop Peanut Butter Cookies Nationwide Because of Possible Health Risk
9. Kellogg Recalls 16 Products as Salmonella Probe Widens
10. PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
11. ETHEX Corporation Initiated Nationwide Voluntary Recalls of Specific Lots of Five Generic Products Due to the Potential for Oversized Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of ... However, for those self-conscious about a double chin, this means more anxiety than elation. ... , “For most people, a double chin is undesirable,” Dr. Goldman said, “but ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... ... , ... With less than 10,000 dermatologists in the United States and more ... while the desire to conquer breakouts and eliminate skincare stress is widespread. Curology ... today released its inaugural survey on the State of Acne in America. , ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The Executives, ... to raise money to for the Toys for Tots Literacy Campaign at their Semi-Annual ... in excess of $70 billion, the U.S. ranks at number 14 internationally in literacy. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Market leading ... announced a partnership with premium news content provider ... companies to extract key insights from Dow Jones ... technology. The Linguamatics I2E platform is ... global pharmaceutical companies. The Linguamatics-Dow Jones partnership helps ...
(Date:3/28/2017)... Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today ... Christopher Gabrieli , partner emeritus ... of the board of Akcea Therapeutics. ... Sandford D. Smith , founder and ... are excited to announce this expansion to our board and ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
Breaking Medicine Technology: